Literature DB >> 23524684

Macrophages: Good guys in colorectal cancer.

Sofia Edin1, Maria L Wikberg, Per-Arne Oldenborg, Richard Palmqvist.   

Abstract

Macrophages play a complex role in tumor progression since they can exert both tumor-preventing (M1 macrophages) and tumor-promoting (M2 macrophages) activities. In colorectal carcinoma (CRC), at odds to many other cancers, macrophage infiltration has been correlated with an improved patient survival. In a recent study, we have evaluated the distribution of M1 and M2 macrophage subtypes in CRC and their impact on patient prognosis.

Entities:  

Keywords:  CpG island methylator phenotype; colorectal cancer; macrophage subtypes; microsatellite instability; prognosis

Year:  2013        PMID： 23524684      PMCID： PMC3601174          DOI： 10.4161/onci.23038

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 2.  Differential macrophage programming in the tumor microenvironment.

Authors:  Brian Ruffell; Nesrine I Affara; Lisa M Coussens
Journal:  Trends Immunol       Date:  2012-01-23       Impact factor: 16.687

Review 3.  Intestinal macrophages: differentiation and involvement in intestinal immunopathologies.

Authors:  Benjamin Weber; Leslie Saurer; Christoph Mueller
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

4.  Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.

Authors:  Marco Erreni; Alberto Mantovani; Paola Allavena
Journal:  Cancer Microenviron       Date:  2010-09-17

Review 5.  The immune contexture in human tumours: impact on clinical outcome.

Authors:  Wolf Herman Fridman; Franck Pagès; Catherine Sautès-Fridman; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2012-03-15       Impact factor: 60.716

6.  High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

Authors:  Johan Forssell; Ake Oberg; Maria L Henriksson; Roger Stenling; Andreas Jung; Richard Palmqvist
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

Review 7.  Macrophage polarization in tumour progression.

Authors:  Antonio Sica; Paola Larghi; Alessandra Mancino; Luca Rubino; Chiara Porta; Maria Grazia Totaro; Monica Rimoldi; Subhra Kumar Biswas; Paola Allavena; Alberto Mantovani
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 8.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

Review 9.  Identification and manipulation of tumor associated macrophages in human cancers.

Authors:  Moniek Heusinkveld; Sjoerd H van der Burg
Journal:  J Transl Med       Date:  2011-12-16       Impact factor: 5.531

10.  The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.

Authors:  Sofia Edin; Maria L Wikberg; Anna M Dahlin; Jörgen Rutegård; Åke Öberg; Per-Arne Oldenborg; Richard Palmqvist
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240
  10 in total
  24 in total

Review 1.  [Tumor-associated macrophages: Function and differentiation].

Authors:  G Niedobitek; M H Barros; J H Dreyer; F Hauck; D Al-Sheikhyaqoob
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

2.  Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC.

Authors:  S A Almatroodi; C F McDonald; I A Darby; D S Pouniotis
Journal:  Cancer Microenviron       Date:  2015-08-30

Review 3.  Trial Watch: Radioimmunotherapy for oncological indications.

Authors:  Norma Bloy; Jonathan Pol; Gwenola Manic; Ilio Vitale; Alexander Eggermont; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110

4.  Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma.

Authors:  Si Li; Fangying Xu; Jing Zhang; Lili Wang; Yang Zheng; Xuesong Wu; Jing Wang; Qiong Huang; Maode Lai
Journal:  Oncoimmunology       Date:  2017-10-11       Impact factor: 8.110

Review 5.  Alveolar Macrophage Polarisation in Lung Cancer.

Authors:  Saleh A Almatroodi; Christine F McDonald; Dodie S Pouniotis
Journal:  Lung Cancer Int       Date:  2014-05-08

Review 6.  The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy.

Authors:  Maurice Michel; Leonard Kaps; Annett Maderer; Peter R Galle; Markus Moehler
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

Review 7.  Macrophage Polarization States in the Tumor Microenvironment.

Authors:  Ava J Boutilier; Sherine F Elsawa
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 6.208

8.  Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates.

Authors:  Tomotaka Ugai; Juha P Väyrynen; Koichiro Haruki; Naohiko Akimoto; Mai Chan Lau; Rong Zhong; Junko Kishikawa; Sara A Väyrynen; Melissa Zhao; Kenji Fujiyoshi; Andressa Dias Costa; Jennifer Borowsky; Kota Arima; Jennifer L Guerriero; Charles S Fuchs; Xuehong Zhang; Mingyang Song; Molin Wang; Marios Giannakis; Jeffrey A Meyerhardt; Jonathan A Nowak; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 11.816

9.  Transmembrane protein 106a activates mouse peritoneal macrophages via the MAPK and NF-κB signaling pathways.

Authors:  Hui Dai; Dong Xu; Jing Su; Jingyuan Jang; Yingyu Chen
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

10.  An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.

Authors:  Charlotte O'Donnell; Amr Mahmoud; Jonathan Keane; Carola Murphy; Declan White; Sinead Carey; Micheal O'Riordain; Michael W Bennett; Elizabeth Brint; Aileen Houston
Journal:  Br J Cancer       Date:  2015-12-17       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.